Bio-Rad Laboratories | BIO - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
Agilent USD 4.62B 21M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Danaher USD 12.76B 3.15B 2025-12
General Electric Aerospace USD 40.6B 522M 2025-12
Hologic USD 3.84B 175.3M 2025-12
Illumina USD 3.29B 493M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Merck USD 47.56B 10.49B 2025-09
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Pacific Biosciences Of California USD 375.05M 19.18M 2025-12
Quest Diagnostics USD 2.38B 29M 2025-12
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Siemens EUR 67.91B 3.2B 2025-12
Standard Biotools USD 454.26M 18.18M 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
Tosoh JPY 759.27B 28.26B 2025-12
Waters USD 1.99B 69.86M 2025-12